Trials / Completed
CompletedNCT03851731
Evaluation of Intranasal Naltrexone and Naloxone
Pharmacokinetic Evaluation of Intranasal Naltrexone and Naloxone Administered Separately and in Combination in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will be to determine the pharmacokinetics of naltrexone and naloxone when administered via intranasal separately and in combination in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naltrexone | Intranasal spray |
| DRUG | Naloxone | Intranasal spray |
| DRUG | Naltrexol | Intranasal spray |
Timeline
- Start date
- 2015-10-05
- Primary completion
- 2015-11-07
- Completion
- 2015-11-07
- First posted
- 2019-02-22
- Last updated
- 2020-09-14
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03851731. Inclusion in this directory is not an endorsement.